Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 14NIH 6NETWORK 5INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Neutropenia 11Leukemia, Myeloid, Acute 9Breast Neoplasms 7Lymphoma, Non-Hodgkin 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma 4Leukemia 4Triple Negative Breast Neoplasms 3Multiple Myeloma 3Leukemia, Biphenotypic, Acute 3Hodgkin Disease 3Carcinoma, Non-Small-Cell Lung 3Recurrence 2Plasmacytoma 2Paraproteinemias 2Pancreatic Neoplasms 2Neoplasms 2Leukemia, Plasma Cell 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Febrile Neutropenia 2Anemia, Refractory, with Excess of Blasts 2Unspecified Adult Solid Tumor, Protocol Specific 1Solid Tumors 1Sarcoma 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Optic Nerve Glioma 1Oligodendroglioma 1Neutropenia in Breast Cancer 1Myelodysplastic Syndromes 1Medulloblastoma 1

Interventions

Granulocyte Colony-Stimulating Factor 1Filgrastim 1Cytarabine 1Clofarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Leukemia, Myelomonocytic, Acute × Filgrastim × Clear all
NCT01031368 2019-03-01

Clofarabine, Cytarabine, and Filgrastim Followed by Infusion of Non-HLA Matched Ex Vivo Expanded Cord Blood Progenitors in Treating Patients With Acute Myeloid Leukemia

Nohla Therapeutics, Inc.

Phase 1 Completed
29 enrolled
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡